SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001144204-09-017660
Filing Date
2009-03-31
Accepted
2009-03-31 14:58:56
Documents
9
Period of Report
2008-12-31
Filing Date Changed
2009-03-31

Document Format Files

Seq Description Document Type Size
1 v144562_10k.htm 10-K 2523105
2 GRAPHIC chart.jpg GRAPHIC 61615
3 v144562_ex10-16.htm EX-10.16 15947
4 v144562_ex21-1.htm EX-21.1 9648
5 v144562_ex23-1.htm EX-23.1 14886
6 v144562_ex31-1.htm EX-31.1 19018
7 v144562_ex31-2.htm EX-31.2 18614
8 v144562_ex32-1.htm EX-32.1 6550
9 v144562_ex32-2.htm EX-32.2 6646
  Complete submission text file 0001144204-09-017660.txt   2700750
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 09718178
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1